The Total revenue for the quarter ended June 2022 of  Rs. 514.00 millions remain, more or less, the same.A slender decline of -28.35% was recorded to Rs. 38.67  millions from Rs. 53.97 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2022 decreased to 64.66 millions as compared to 83.29 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 514.00 512.69 0.26 514.00 512.69 0.26 2196.63 2448.05 -10.27
Other Income 29.80 13.31 123.89 29.80 13.31 123.89 119.93 71.41 67.95
PBIDT 64.66 83.29 -22.37 64.66 83.29 -22.37 314.56 449.80 -30.07
Interest 5.04 1.89 166.67 5.04 1.89 166.67 13.55 2.71 400.00
PBDT 59.62 81.75 -27.07 59.62 81.75 -27.07 301.25 447.39 -32.67
Depreciation 9.95 9.71 2.47 9.95 9.71 2.47 39.48 40.35 -2.16
PBT 49.67 72.04 -31.05 49.67 72.04 -31.05 261.77 407.04 -35.69
TAX 11.00 18.07 -39.13 11.00 18.07 -39.13 63.86 115.32 -44.62
Deferred Tax 0.70 -0.06 -1266.67 0.70 -0.06 -1266.67 1.40 2.31 -39.39
PAT 38.67 53.97 -28.35 38.67 53.97 -28.35 197.91 291.72 -32.16
Equity 940.00 789.95 18.99 940.00 789.95 18.99 862.45 789.95 9.18
PBIDTM(%) 12.58 16.25 -22.57 12.58 16.25 -22.57 14.32 18.37 -22.06

Syncom Formulations Share Price

14.43 -0.25 (-1.70%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×